Drugs / Trilostane
last change Oct 2013 re-read 2 minutes ago

Trilostane

Small molecule targets HSD3B2 via inhibition

Developed for
prostate adenocarcinoma
Investigated by
Genzyme, a Sanofi Company

Regulatory milestones approvals, filings & regulatory actions · 1 recorded

MilestoneJurisdictionBrandIndicationDateSentence it was read from
Approved US (FDA) MODRASTANE 1984-12-31 fda.gov

Trials 1 · a red edge is where a trial was stopped

today
US approved 1984
NCT00181597 · Ph 2
19841985198619871988198919901991199219931994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT00181597 Mar 2004 → Jan 2006 prostate adenocarcinoma Genzyme, a Sanofi Company Completed No outcome recorded
Also used as a comparator or background therapy in 1 trial
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT01615211 Comparator May 2012 → Oct 2013 Kristina Gemzell Danielsson Terminated No outcome recorded

Evidence & citations 14 cited values

Every value below carries the sentence it was read from. 3 sources stand behind the page.

FieldValueCited text
Known as Trilostane ClinicalTrials.gov intervention name — accepted as the source's own label NCT01615211
1

NCT00181597

Known as Brand name Modrenal Brand name ModrenalNCT01615211
Known as Desopan ChEMBL registry synonym — accepted as the source's own label CHEMBL1200907
Known as Modrastane ChEMBL registry synonym — accepted as the source's own label CHEMBL1200907
Known as Modrenal ChEMBL registry synonym — accepted as the source's own label CHEMBL1200907
Known as NSC-758904 ChEMBL registry synonym — accepted as the source's own label CHEMBL1200907
Known as Trilocur ChEMBL registry synonym — accepted as the source's own label CHEMBL1200907
Known as Trilorale ChEMBL registry synonym — accepted as the source's own label CHEMBL1200907
Known as Trilostano ChEMBL registry synonym — accepted as the source's own label CHEMBL1200907
Known as WIN 24,540 ChEMBL registry synonym — accepted as the source's own label CHEMBL1200907
Action Inhibit “3-beta-hydroxysteroid dehydrogenase/delta 5-->4-isomerase type II inhibitor” CHEMBL1200907
Modality Small molecule CHEMBL1200907
Route Oral “Taken orally once a day for three days then twice daily thereafter.” NCT00181597
Target HSD3B2 “3-beta-hydroxysteroid dehydrogenase/delta 5-->4-isomerase type II inhibitor” CHEMBL1200907